Abstract

37MO Niraparib maintenance therapy in patients with newly diagnosed advanced ovarian cancer: A post hoc analysis on efficacy by surgical timing and residual disease status in the phase III PRIME trial

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call